News
Updated ANZPID Statement on Primary School aged (5-to 11-year-olds) children and COVID vaccines
The Australian and New Zealand Paediatric Infectious Diseases Group (ANZPID) of the Australasian Society for Infectious Diseases (ASID) supports the Therapeutic Goods Administration (TGA) and Australian Technical Advisory Group on Immunisation (ATAGI) advice on COVID vaccinations for 5-to 11-year-olds in Australia, following their review of safety and efficacy data on these vaccines in children.
Joint Statement with the Australian and New Zealand Society of Nephrology (ANZSN) - Vaccination against COVID-19 for Adult Patients with Kidney Failure Requiring Transplantation or Dialysis
The Australian and New Zealand Society of Nephrology (ANZSN) and the Australasian
Society for Infectious Diseases (ASID) strongly recommend that adult patients with kidney
failure requiring dialysis or transplantation are vaccinated against COVID-19, using any of the available vaccines that have been approved by the TGA and endorsed by ATAGI, or approved by Medsafe and in accordance with New Zealand Ministry of Health Guidelines.
Joint Statement with the New Zealand Sepsis Trust - COVID-19 exacerbates the existing burden of sepsis on the healthcare system
The solutions are there to reduce inequity and unnecessary harm, and must be urgently embraced through the government’s health reforms. That’s the key message from the upcoming New Zealand Sepsis Conference 2021 and the newly revised National Sepsis Action Plan.